Back to Results
First PageMeta Content
Patient safety / Pharmacology / Clinical pharmacology / Medical prescription / Pharmacy / Methadone / Ivacaftor / Chemistry / Pharmaceutical sciences / Organic chemistry


Typical  Patient  Questions  Regarding  Kalydeco  Access     What  patients  can  access  Kalydeco?   Patients  with  the  G551D  mutation  6  years  of  age
Add to Reading List

Document Date: 2014-11-06 18:46:00


Open Document

File Size: 108,39 KB

Share Result on Facebook

Company

Vertex / /

Country

Australia / /

Facility

CF Clinic / /

IndustryTerm

online program / /

MedicalCondition

cystic fibrosis / /

Position

Federal Minister / Minister of Health / treating physician / CF Respiratory Physician / CF specialist / treating CF specialist / CF Physician / treating specialist / /

Product

Kalydeco / /

ProvinceOrState

Tasmania / /

Technology

genotype / /

SocialTag